Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin:: study of sixteen patients

被引:0
|
作者
Rocca, P
Bailly, FO
Chevallier, M
Chevallier, P
Zoulim, F
Trépo, C
机构
[1] Hop Hotel Dieu, Serv Hepatol & Gastroenterol, Lyon, France
[2] Lab Marcel Merieux, Serv Anat Pathol, Lyon, France
[3] Fac Med Rockefeller, Virol Lab, Lyon, France
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2003年 / 27卷 / 03期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim of the study -To assess the mode of transmission and the efficacy of antiviral therapy in the outcome of treated and untreated patients with acute hepatitis C. Patients and methods - From December 1995 to January 2001, 16 consecutive patients and their response to therapy were studied, including clinical, biochemical, virological and histological data. Results - Hepatitis C virus (HCV) exposure was IVDU (38%), needle-stick injury (19%.), medical procedure (6%), piercing (6%), suspected sexual contact (19%), and unknown in 2. Among 73 patients treated for acute hepatitis C, all 12 patients who completed therapy had a biochemical and virological sustained response for more than 15 months (range: 4-36 months) after stopping therapy. Therapy was tolerated in all but one patient, who stopped after 10 weeks because of side effects. Duration of treatment, type of interferon and combination with ribavirin did not modify the response to treatment. Conclusion - These results suggest that early intervention with interferon alpha is effective in preventing the progression of acute HCV infection to chronic hepatitis in most patients regardless of duration, type of interferon, or combination with ribavirin.
引用
收藏
页码:294 / 299
页数:6
相关论文
共 50 条
  • [31] ALPHA-2B INTERFERON AND HYPOTHYROIDISM
    JAVIER, RM
    SIBILIA, J
    KUNTZ, JL
    SCHLIENGER, JL
    ASCH, L
    REVUE DU RHUMATISME, 1992, 59 (7-8): : 501 - 501
  • [32] Interferon alpha-2b and ribavirin for interferon monotherapy non-responders.
    Herrine, SK
    Conn, MI
    Jefferson, T
    Greenfield, SM
    Shaw, EW
    Thornton, JJ
    Weinberg, DS
    HEPATOLOGY, 1999, 30 (04) : 370A - 370A
  • [33] TREATMENT OF CHRONIC HEPATITIS-B WITH RECOMBINANT ALPHA-2B INTERFERON
    MULLER, R
    BAUMGARTEN, R
    MARKUS, R
    SCHULZ, M
    WITTENBERG, H
    HINTSCHEKILGER, B
    FENGLER, JD
    VONWUSSOW, P
    MEISEL, H
    KLEIN, H
    MALMUS, K
    SCHMIDT, FW
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 115 (11) : 403 - 407
  • [34] Trichomegaly following treatment with interferon alpha-2b
    Hernández-Núnéz, A
    Fernández-Herrera, J
    Buceta, LR
    García-Díez, A
    LANCET, 2002, 359 (9312): : 1107 - 1107
  • [35] A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy
    Younossi, ZM
    Mullen, KD
    Zakko, W
    Hodnick, S
    Brand, E
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Boparai, N
    Gramlich, T
    JOURNAL OF HEPATOLOGY, 2001, 34 (01) : 128 - 133
  • [36] A randomized controlled trial of pegylated-interferon alpha-2b plus ribavirin vs interferon
    Pol, S
    Perronne, C
    Carrat, F
    Banisadr, F
    Morand, P
    Lunel, F
    Rosenthal, E
    JOURNAL OF HEPATOLOGY, 2003, 38 : 32 - 32
  • [37] Efficacy and safety of pegylated interferon alpha-2b and ribavirin in chronic hepatitis C in children
    Kups-Rzepecka, Joanna
    Golabek, Violetta
    Kicinski, Przemyslaw
    Wozniakowska-Gesicka, Teresa
    PRZEGLAD GASTROENTEROLOGICZNY, 2010, 5 (06): : 341 - 348
  • [38] TREATMENT OF ACUTE NON-A, NON-B HEPATITIS WITH INTERFERON ALPHA-2B
    TASSOPOULOS, NC
    KOUTELOU, M
    PAPATHEODORIDIS, G
    POLYCHRONAKI, H
    GIANNIKAKIS, T
    PARALOGLOUIOANNIDES, M
    HATZAKIS, A
    INFECTION, 1992, 20 (04) : 242 - 242
  • [39] Interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis
    Ferrara, F.
    Baldo, V.
    Rizzotto, E. Rosa
    Carderi, I.
    Baldovin, T.
    Minola, E.
    Floreani, A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S223 - S223
  • [40] TREATMENT OF ESSENTIAL THROMBOCYTHEMIA WITH INTERFERON ALPHA-2B
    MAY, D
    WANDL, UB
    NIEDERLE, N
    LANCET, 1989, 1 (8629): : 96 - 96